Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

Integrating multi-omic approaches and preclinical model development to guide precision therapy in gastroenteropancreatic neuroendocrine neoplasms

FY 2024-25

Summary
Rare cancers that develop from hormone-producing cells in the digestive tract and pancreas, called gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), are becoming increasingly common worldwide. These tumours are highly diverse, ranging from slow-growing to aggressive, making them hard to manage. Most patients are diagnosed after the cancer has already spread, and even though treatments are available to control disease growth, their effectiveness varies widely. This creates a need for better, more personalized approaches to care. Precision medicine;tailoring treatments to the unique characteristics of each patient tumour;has transformed cancer care in many areas, but GEP-NENs have lagged behind. This is because their complex biology is not fully understood, and researchers face challenges such as limited high-quality evidence from existing molecular data and a lack of realistic lab models. This proposal seeks to tackle these barriers through three interconnected approaches. First, I will analyze genomic data from GEP-NENs to identify patterns that could predict how these tumours behave or respond to specific treatments. Second, I will examine how sugar molecules in cells (the glycome) are altered in GEP-NENs. Early findings from our work suggest that these changes may play a role in cancer progression and could be leveraged to identify new therapeutic targets. Finally, I will help develop 3D tumour models called organoids, which mimic real tumours in the lab. These organoids will allow us to test new drugs and validate targets discovered in the genomic and glycomic studies.Together, these efforts will advance precision medicine for GEP-NENs, potentially leading to better treatments and outcomes for patients facing this challenging disease.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529890
Name
Zaidi Syed A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Integrating multi-omic approaches and preclinical model development to guide precision therapy in gastroenteropancreatic neuroendocrine neoplasms
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Biomarkers; Cancer; Gastroenteropancreatic Neuroendocrine Neoplasms; Genomics; Glycomics; Multi-Omics; Patient-Derived Organoids; Precision Medicine; Preclinical Models
Abstract
Rare cancers that develop from hormone-producing cells in the digestive tract and pancreas, called gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), are becoming increasingly common worldwide. These tumours are highly diverse, ranging from slow-growing to aggressive, making them hard to manage. Most patients are diagnosed after the cancer has already spread, and even though treatments are available to control disease growth, their effectiveness varies widely. This creates a need for better, more personalized approaches to care. Precision medicine;tailoring treatments to the unique characteristics of each patient tumour;has transformed cancer care in many areas, but GEP-NENs have lagged behind. This is because their complex biology is not fully understood, and researchers face challenges such as limited high-quality evidence from existing molecular data and a lack of realistic lab models. This proposal seeks to tackle these barriers through three interconnected approaches. First, I will analyze genomic data from GEP-NENs to identify patterns that could predict how these tumours behave or respond to specific treatments. Second, I will examine how sugar molecules in cells (the glycome) are altered in GEP-NENs. Early findings from our work suggest that these changes may play a role in cancer progression and could be leveraged to identify new therapeutic targets. Finally, I will help develop 3D tumour models called organoids, which mimic real tumours in the lab. These organoids will allow us to test new drugs and validate targets discovered in the genomic and glycomic studies.Together, these efforts will advance precision medicine for GEP-NENs, potentially leading to better treatments and outcomes for patients facing this challenging disease.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zaidi, Syed A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~